|
|
The inactive X: discovering sex genes that influence female vulnerability to Alzheimers disease |
| 1DP2AG082342-01 |
|
NIA |
2022 |
|
|
Quantitative Magnetization Transfer Imaging for Early Detection of Alzheimers Disease |
| 1F30AG077794-01 |
|
NIA |
2022 |
|
|
Leveraging Clinical Data for Phenotyping and Predictive Modelling of Alzheimer’s Disease |
| 1F30AG079504-01 |
|
NIA |
2022 |
|
|
Refining the Use of Polygenic Risk Scores for Alzheimers Disease in Diverse and Founder Populations |
| 1F31AG072715-01A1 |
|
NIA |
2022 |
|
|
Functional Competence in Alzheimers Disease: A Novel Assessment Approach to Enhance Prediction of Risk in the Elderly |
| 1F31AG072904-01A1 |
|
NIA |
2022 |
|
|
From stress to dementia risk: An examination of psychological, immunological, and neurobiological mechanisms underlying increased risk for Alzheimer’s disease and related dementias in widow(er)s |
| 1F31AG074648-01A1 |
|
NIA |
2022 |
|
|
Role of age-associated epigenetic repetitive element derepression in Alzheimers Disease |
| 1F31AG079594-01 |
|
NIA |
2022 |
|
|
Functional networks underlying cognitive decline in aging and Alzheimers disease |
| 1F31AG079595-01 |
|
NIA |
2022 |
|
|
Plasma Phosphorylated-Tau, Neurodegeneration, and Clinical Outcomes |
| 1F32AG076276-01 |
|
NIA |
2022 |
|
|
Elucidating the role of endocrine aging as a risk factor for Alzheimers Disease |
| 1F99AG079790-01 |
|
NIA |
2022 |
